Fig. 4From: Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient dataMaximum day 3 parasite positivity rate (PPR) possible for each of the treatment regimens for a given study sample size. Worst-case estimates were used for the analysis, that is, an upper limit of 95Â % CI was assumed to be the true underlying parasite positivity rate on day 3, which was 0.82Â %, 0.94Â % and 1.42Â % for AL, ASAQ-FDC and DP, respectively. The horizontal solid line represents 10Â %Â day 3 WHO threshold and the dotted horizontal line represents 5Â %Â day 3 PPR. The saw-tooth spikes are the result of rounding to the nearest whole number. ACT, artemisinin-based combination therapy; AL, artemether-lumefantrine; ASAQ-FDC, fixed dose combination; DP, dihydroartemisinin-piperaquine; PPR, parasite positivity rateBack to article page